The first treatment for levodopa-induced dyskinesia — the involuntary and jerky movements that afflict most Parkinson’s disease patients on this common therapy — was approved Thursday, Aug. 24, by the U.S. Food and Drug Administration. The therapy, Gocovri (amantadine) by Adamas Pharmaceuticals, is an long-acting and extended-release capsule, indicated for those…
News
In-home senior care provider Senior Helpers has purchased Elmhurst, Illinois-based Handle with Care, a company founded by Julie Kastholm and Debbie Russell that has been providing dignified, trusted home care since 2009 to seniors in the greater Chicago area. Handle with Care’s caregivers assist their clients with everyday activities…
News
Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Virtual house calls with a neurologist can be as effective as in-person visits for Parkinson’s disease patients, offering convenience and comfort, a clinical trial indicates. The study, “National randomized controlled trial of virtual house calls for Parkinson disease,” was published in the journal Neurology.
The biopharmaceutical company Cavion announced the appointment of a new executive vice president of research and development and chief medical officer to lead efforts advancing therapies based on the company’s T-type calcium channel (Cav3) platform targeting neurological diseases such as Parkinson’s disease (PD). Spyridon “Spyros” Papapetropoulos, MD, PhD, has been named the…
The online Parkinson’s disease community GeneFo and Greg Macpherson, MitoQ‘s CEO, will conduct a free webinar on Aug. 24, at 1 p.m. EST, to shed light on the latest results of mitochondria-targeting therapies and what the future might bring to patients suffering from Parkinson’s and other neurodegenerative diseases. In the webinar, titled…
Brain proteins called granulins — previously thought to be toxic — might play a crucial role in brain health, according to a study that suggests the proteins might be linked to several neurodegenerative diseases, including Parkinson’s. The identification of a new tool to track the proteins allowed Emory University…
The Parkinson’s Foundation will award $1.2 million to early career scientists working on Parkinson’s disease research in 27 new career development and fellowship grants. Xi Chen, PhD, of the Van Andel Research Institute, was called a “standout grand recipient” this year. Chen is using a $100,000 postdoctoral fellowship…
News
Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Singing may help people with Parkinson’s disease — especially in its earlier stages — because it strengthens muscles involved in swallowing and respiratory control, suggests two studies from researchers at Iowa State University. One study, “Therapeutic singing as an early intervention for swallowing in persons with Parkinson’s disease,” was published in…
The naturally-occurring protein α-klotho improves cognition and brain resilience in mice, and may have potential benefits for Parkinson’s disease (PD) and Alzheimer’s disease (AD), researchers showed. The study, ”Peripheral Elevation of a Klotho Fragment Enhances Brain Function and Resilience in Young, Aging, and α-Synuclein Transgenic Mice,” appeared…
Jonathan Silverstein’s two decades as a healthcare venture capitalist gave him the solid background he needed to be a success in his career. But it didn’t quite prepare him for his diagnosis last year at age 49 with Parkinson’s disease with a rare mutation in the GBA gene. Although…
Recent Posts
- My experiences with the stages of grief since my Parkinson’s diagnosis
- How a simple plant protein could help clear Parkinson’s toxins
- First patient in US trial gets new off-the-shelf cell therapy for Parkinson’s
- When I became the unofficial offensive line in Parkinson’s quiet game
- The GPS of Theseus: Training the body’s navigation system with Parkinson’s